SCHEMBL4889207

SCHEMBL4889207

COc1cccc(-c2cccc(-c3nc(CCOc4ccc(CCC(=O)O)c(C(N)C(=O)OC(C)C)c4)c(C)o3)c2)c1

nearest known ligand 0.58

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PPARG P37231 19/20 0.58
PPARA Q07869 18/20 0.58
PPARD Q03181 4/20 0.51
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4907789 0.98 PPARG (0.59) PPARGPPARAPPARDKDM4EALDH1A1
SCHEMBL5346302 0.96 PPARG (0.62) PPARGPPARAPPARD
SCHEMBL4893935 0.93 PPARG (0.60) PPARGPPARAPPARD
SCHEMBL4893731 0.93 PPARG (0.59) PPARGPPARAPPARD
SCHEMBL4891612 0.92 PPARG (0.64) PPARGPPARAPPARD
SCHEMBL4915180 0.91 PPARG (0.61) PPARGPPARAPPARD
SCHEMBL4898650 0.91 PPARG (0.69) PPARGPPARAPPARD
SCHEMBL4896536 0.90 PPARG (0.62) PPARGPPARAPPARD
SCHEMBL4898681 0.90 PPARG (0.57) PPARGPPARAPPARD
SCHEMBL4897356 0.90 PPARG (0.57) PPARGPPARAPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080167310-A1 MODULATORS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS (PPAR) GOSSETT LYNN STACY 2008-07-10 US disclosed
US-7282501-B2 Modulators of peroxisome proliferator activated receptors (PPAR) ELI LILLY AND COMPANY (US) 2007-10-16 US disclosed
US-20050075378-A1 Modulators of peroxisome proliferator activated receptors (ppar) ELI LILLY AND COMPANY 2005-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050075378-A1 Modulators of peroxisome proliferator activated receptors (ppar) PPARG, PPARA, PPARD PPARG 1/4885PPARA 2/4885PPARD 3/4885
US-20080167310-A1 MODULATORS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS (PPAR) PPARG, PPARA, PPARD PPARG 1/4885PPARA 2/4885PPARD 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.